Equity · Healthcare
AMGN
NASDAQAmgen (AMGN)
The line runs 443.80 USD on 24 August through 436.05 USD on 20 November, on a scale from 350 to 500. Days the market did not trade hold the previous close, flat.
- Market cap
- 235.9B USD
- P/E (TTM)
- 25.3
- Revenue, year to Dec 2025
- 36.8B USD
- EPS, diluted, year to Dec 2025
- 14.23 USD
- 52-week range
- 313.86 USD – 478.98 USD
- Avg volume
- 102.4K
- Mentions, 30 days
- 12
- Net sentiment
- +0.27
as of Nov 20, 2026
Have Amgen (AMGN) insiders bought or sold shares recently?
In the 90 days to 21 Nov 2026, no Amgen insider bought or sold shares on the open market; all 4 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Form 4, 90 days to 21 Nov 2026, newest Form 4 filing 6 Nov 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 06 Nov 2026 | Drake Michael VDirector | Award | 114 | |
| 06 Nov 2026 | Gibbs David WDirector | Award | 278 | |
| 06 Nov 2026 | HOLLEY CHARLES MDirector | Award | 185 | |
| 06 Nov 2026 | ISHRAK OMARDirector | Award | 152 |
Which funds hold Amgen (AMGN)?
13 of the 45 institutional funds we track reported a Amgen position for the quarter ended 30 Sep 2026 — a combined 2.2B USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Held (±25%) | 1,691,691 | 713.1M USD | +6.4% |
| Citadel Advisors | Held (±25%) | 649,141 | 273.6M USD | −7.8% |
| Balyasny Asset Management | Added | 532,493 | 224.5M USD | +2,867.5% |
| AQR Capital Management | Added | 524,758 | 221.2M USD | +74.9% |
| Man Group | Added | 462,476 | 194.9M USD | +97.6% |
| D. E. Shaw & Co. | Trimmed | 405,693 | 171.0M USD | −68.6% |
| Two Sigma Investments | Trimmed | 317,977 | 134.0M USD | −71.8% |
| Marshall Wace | Added | 220,860 | 93.1M USD | +122.2% |
| Millennium Management | Added | 200,409 | 84.5M USD | +152.6% |
| Bridgewater Associates | Added | 114,655 | 48.3M USD | +424.3% |
Showing the 10 largest of 13 reported positions. The figures above count all of them.
Have members of Congress traded Amgen (AMGN)?
The most recent congressional trade disclosed in Amgen is a sale by David J. Taylor (house, OH), dated 03 Nov 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 03 Nov 2026 | David J. Taylorhouse · Republican–OH | Sale | 1K USD–15K USD | 9 days |
| 15 Oct 2026 | Sheldon Whitehousesenate · Democrat–RI | Sale | 15K USD–50K USD | 18 days |
| 22 Sep 2026 | David J. Taylorhouse · Republican–OH | Purchase | 1K USD–15K USD | 9 days |
| 26 Aug 2026 | David J. Taylorhouse · Republican–OH | Sale | 1K USD–15K USD | 10 days |
| 05 Jun 2026 | David J. Taylorhouse · Republican–OH | Purchase | 1K USD–15K USD | 7 days |
| 26 Feb 2026 | David J. Taylorhouse · Republican–OH | Sale | 1K USD–15K USD | 8 days |
| 16 Jan 2026 | David J. Taylorhouse · Republican–OH | Purchase | 1K USD–15K USD | 17 days |
| 03 Dec 2025 | David J. Taylorhouse · Republican–OH | Sale | 1K USD–15K USD | 2 days |
Amgen (AMGN) US federal contracts
US federal agencies committed 126.0M USD in contracts to Amgen (AMGN) in fiscal 2026, the year to 30 Sep 2026, against 89.9M USD the year before.
USAspending.gov
| Signed | Agency | Contract | Committed |
|---|---|---|---|
| 12 Mar 2024 | Office of Assistant Secretary for Preparedness and ResponseDepartment of Health and Human Services | VENDOR MANAGED INVENTORY (VMI) SERVICES FOR USG PROCURED 165,906 DOSES OF NEULASTA PRODUCT TO MITIGATE INJURIES CAUSED BY EXPOSURE TO…HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT · 75A50124C00011 · AMGEN USA INC | 812K USD |
| 28 Sep 2022 | Office of Assistant Secretary for Preparedness and ResponseDepartment of Health and Human Services | TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT · 75A50122C00065 · AMGEN USA INC | 839.9M USD |
Contracts of US$100,000 or more signed since April 2022; the amount is what the government has committed so far, which grows when options are exercised. Defense Department contracts are published about 90 days after signing, so the latest year is still filling in.
What has been filed or recorded for Amgen (AMGN)?
The filings we hold for Amgen, newest first: 10 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Oct 2026 | Fails to deliver | Shares failed to deliver | 495 shares | 228K USD notional · <0.001% of shares out |
| 28 Oct 2026 | Fails to deliver | Shares failed to deliver | 9,195 shares | 4.1M USD notional · 0.002% of shares out |
| 26 Oct 2026 | Fails to deliver | Shares failed to deliver | 2,365 shares | 1.0M USD notional · <0.001% of shares out |
| 23 Oct 2026 | Fails to deliver | Shares failed to deliver | 5 shares | 2K USD notional · <0.001% of shares out |
| 21 Oct 2026 | Fails to deliver | Shares failed to deliver | 802 shares | 352K USD notional · <0.001% of shares out |
| 19 Oct 2026 | Fails to deliver | Shares failed to deliver | 210 shares | 91K USD notional · <0.001% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 447 shares | 187K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 114 shares | 46K USD notional · <0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 1 shares | 413 USD notional · <0.001% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 22 shares | 9K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 7.08 USD | |
| 30 Sep 2026 | Financials | Total assets | 96.0B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 14.4B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 4.37 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 3.34 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 14.23 USD | |
| 31 Dec 2025 | Financials | Revenue | 36.8B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 7.7B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 14.23 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 5.93 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 2.65 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 3.20 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 7.56 USD |
What is Reddit saying about Amgen (AMGN)?
Reddit mentioned AMGN 12 times in the 30 days to 21 November 2026, across 4 of the communities we track. All of them were scored for sentiment: 83% read bullish, 0% bearish and 17% neither. Reddit data updated 21 November 2026.
30-day window, Method
How do Reddit mentions of Amgen (AMGN) compare with its price?
Share ↗
Which subreddits are talking about Amgen (AMGN)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 50% | 6 | +0.19 |
| r/stocks | 33% | 4 | +0.40 |
| r/investing | 8% | 1 | +0.51 |
| r/etfs | 8% | 1 | +0.01 |
Which names move with Amgen (AMGN) on Reddit?
OI moved most closely with Amgen (AMGN): when the crowd talked about one, it talked about the other (+0.54 over 31 days). Co-discussion, not price.
MES | Chinese EVS | |||||
|---|---|---|---|---|---|---|
AMGN | +0.54 | +0.45 | +0.45 | +0.42 | −0.45 | −0.52 |
View the matrix as a tableHide the table
| Pair | Match | Days measured |
|---|---|---|
| AMGN and OI | +0.54 | 31 days |
| AMGN and MES | +0.45 | 31 days |
| AMGN and DOCN | +0.45 | 31 days |
| AMGN and BERZ | +0.42 | 31 days |
| AMGN and Chinese EVS | −0.45 | 31 days |
| AMGN and LUV | −0.52 | 31 days |
What do people ask about Amgen (AMGN)?
What did Amgen shares close at?436.05
Amgen closed at 436.05 USD on 20 Nov 2026, down 0.65% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Amgen’s market cap?235.9B
Amgen is worth 235.9B USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Amgen’s P/E ratio?25.3
Amgen has a price-to-earnings ratio of 25.3, as of 20 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Amgen’s revenue?36.8B
Amgen reported revenue of 36.8B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Amgen insiders bought or sold shares recently?4 filings
In the 90 days to 21 Nov 2026, no Amgen insider bought or sold shares on the open market; all 4 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders
Which funds own Amgen?13 of 45
13 of the 45 funds we track reported a Amgen position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Fisher Asset Management, Citadel Advisors and Balyasny Asset Management. See Funds
Have members of Congress traded Amgen?38 trades
Yes. 38 trades in Amgen appear in the congressional disclosures we hold; the latest is a sale by David J. Taylor (House, OH) dated 3 Nov 2026, filed 12 Nov 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Amgen last report earnings?7.08
Amgen last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 7.08 USD; no next date is announced in SEC filings yet. See Filings
Does Amgen have government contracts?126.0M
Yes. US federal agencies committed 126.0M USD in contracts to it in fiscal 2026, the year to 30 Sep 2026 (USAspending.gov). See Contracts
What is Reddit saying about Amgen?2 mentions
Amgen was mentioned 2 times in the last 7 days across the finance subreddits we track, and 12 times over the trailing 30 days. Of the 12 mentions scored for sentiment, 83% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Sheldon Whitehouse: Wikimedia Commons, Public domain; David J. Taylor: Ike Hayman, House Creative Services, Public domain.
- Congress disclosuresU.S. House of Representatives financial disclosures · Source: U.S. Senate financial disclosures
- USAspendingUSAspending.gov (U.S. Department of the Treasury), federal prime contract awards
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Amgen